genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
Bayer Approach to Partnerships, Pipelines, and Platforms
Genomics
Genomics in the Clinic: A Candid Conversation with Sema4 CEO Eric…
Circulating Tumor Cell
Illumina Launching Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform
Biomarkers
Guardant Health Launches Early-Stage Colorectal Cancer ctDNA Assay
GEN Edge
EY Firepower Report: Biopharma M&A Poised to Rebound in 2021
News
Antisense
Antisense Oligo Targets IRF4 Gene to Treat Multiple Myeloma
Drug Discovery
Novel Promising Anti-Fungal Compound Identified in Ant Nests
Cancer
Promising Triple Therapy Approach Identified for Renal Cell Carcinoma
Neuroscience
Deep Sleep Aids in Neurodegenerative Disease Prevention
Cancer
Mathematical Model Captures Relationship between Speed and Surface in Cell Movement
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
Biopharma Manufacturers Shouldn’t Rush When “Going Digital”
Bioprocessing
Separating Cells with Microfluidics
Trends for 2021
Beyond 2021: Cell Therapy Manufacturing Trends
Bioprocessing
Machine Learning for Better Bioprocess Data Analysis
A-Lists
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Antisense
Antisense Oligo Targets IRF4 Gene to Treat Multiple Myeloma
Drug Discovery
Novel Promising Anti-Fungal Compound Identified in Ant Nests
Cancer
Promising Triple Therapy Approach Identified for Renal Cell Carcinoma
Cancer
Mathematical Model Captures Relationship between Speed and Surface in Cell Movement
Magazine
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
January 2021 Vol. 41 No. 1
Leroy Hood: Reflections on a Legendary Career
January 2021 Vol. 41 No. 1
COVID-19 One Year Later: The Biology and the Business
Traditional Medicine
Monoclonal Antibodies: Developers Explore New Territories
Roundtable
Uncharted Territory: Top Challenges Facing Gene Therapy Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Neurological Disorders
ALS
ALS
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
ALS
Steering Stem Cells to Repair Sites Using Inflammo-Free Inflammo-Attraction
Sponsored
Working with ALS Mice: Guidelines for Preclinical Testing and Colony Management
ALS
Neurodegenerative Treatments Build to a Tipping Point
ALS
Is ALS More Genetically Driven than Once Thought?
ALS
Sanofi, Denali Launch $1B+ Alliance to Develop RIPK1 Inhibitors for Neurological, Inflammatory Diseases
ALS
Amyloids Shown to Also Play Beneficial Role in Developing Healthy Muscle...
ALS
Axovant Licenses Benitec Gene Therapy Candidates for OPMD, Neurological Disorders
ALS
Flex Pharma Axes 60% of Workforce, Explores Sale after Halting Phase...
ALS
Neuraltus Weighs Future of Lead Candidate NP001 after Failure in Phase...
ALS
Biogen, Ionis Launch $1B+ Expanded Neuro Drug Partnership, following Spinraza Success
ALS
Novel Research Model Offers Hope to ALS and MS Patients
ALS
Hardening of the RNA Condensates May Solidify Neurodegeneration
ALS
Hope for ALS Patients Comes from New Understanding of RNA Metabolism...
ALS
CRISPR Screen Identifies Genetic Modifiers of ALS
ALS
CRISPR Human Knockout Screens Identify New Target for ALS
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Flex Pharma cites unspecified “oral tolerability concerns” in halting Phase II trials of FLX-787 in amyotrophic lateral sclerosis (ALS) and Charcot-Marie-Tooth (CMT). [© whitehoune / Fotolia]](https://www.genengnews.com/wp-content/uploads/2018/08/170123090806_1_900x6009916143062-324x160.jpg "Flex Pharma Axes 60% of Workforce, Explores Sale after Halting Phase II Trials in ALS, CMT")
![The hnRNP A1B is expressed in the central nervous system and forms cytoplasmic aggregates in ALS patient neurons. [CRCHUM]](https://www.genengnews.com/wp-content/uploads/2018/08/Mar19_2018_CRCHUM_hnRNPA1B2262381965-324x160.jpg "Hope for ALS Patients Comes from New Understanding of RNA Metabolism Misregulation")
